Clinical Trials Arena on MSN
Agenus’ metastatic colorectal cancer combo achieves 33% three-year OS rate
Three-year data from the Phase Ib trial of BOT+BAL was unveiled at ESMO GI 2026.
Showcase your company news with guaranteed exposure both in print and online Join us for an unforgettable evening of inspiration and empowerment at the Outstanding Women in… Tech Tomorrow 2026 offers ...
Teams are scrapping content that may be working because the goal post got moved. Here's what to measure when clicks stop ...
Path Planning,Point Cloud,Quadruped Robot,Legged Robots,Proximal Policy Optimization,Model Predictive Control,Topographic Maps,Mobile Manipulator,Robotic Arm,Actuator ...
Discusses Preliminary Phase II Results for SNT-4728 in Isolated REM Sleep Behavior Disorder July 5, 2026 11:30 PM ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果